Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

STANOZOLOL: 176 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
176
Total FAERS Reports
38 (21.6%)
Deaths Reported
109
Hospitalizations
176
As Primary/Secondary Suspect
36
Life-Threatening
1
Disabilities
May 14, 1984
FDA Approved
Discontinued
Status

FDA Application: 012885 ·

First Report: 19960314 · Latest Report: 20250702

What Are the Most Common STANOZOLOL Side Effects?

#1 Most Reported
Drug abuse
93 reports (52.8%)
#2 Most Reported
Intentional product misuse
30 reports (17.0%)
#3 Most Reported
Left ventricular hypertrophy
26 reports (14.8%)

All STANOZOLOL Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Drug abuse 93 52.8% 28 54
Intentional product misuse 30 17.1% 10 25
Left ventricular hypertrophy 26 14.8% 13 13
Off label use 17 9.7% 2 11
Acute kidney injury 15 8.5% 0 15
Testicular atrophy 15 8.5% 10 4
Acute myocardial infarction 14 8.0% 0 12
Toxicity to various agents 14 8.0% 14 2
Hyperthyroidism 13 7.4% 0 13
Focal segmental glomerulosclerosis 12 6.8% 0 12
Drug-induced liver injury 11 6.3% 0 9
Hypertension 11 6.3% 4 11
Product use in unapproved indication 11 6.3% 0 10
Acute respiratory distress syndrome 10 5.7% 0 10
Chronic kidney disease 10 5.7% 0 10
End stage renal disease 10 5.7% 0 10
Muscle mass 10 5.7% 9 1
Myocardial fibrosis 10 5.7% 9 1
Myocarditis 10 5.7% 0 4
Pneumonia 10 5.7% 0 9

Who Reports STANOZOLOL Side Effects? Age & Gender Data

Gender: 11.1% female, 88.9% male. Average age: 31.0 years. Most reports from: IT. View detailed demographics →

Is STANOZOLOL Getting Safer? Reports by Year

YearReportsDeathsHosp.
2016 4 0 4
2017 1 0 1
2019 2 0 1
2022 9 0 2
2023 5 4 5
2024 2 0 1
2025 1 0 0

View full timeline →

What Is STANOZOLOL Used For?

IndicationReports
Product used for unknown indication 61
Muscle building therapy 25
Supplementation therapy 14
Performance enhancing product use 12
Drug abuse 11
Intentional product misuse 8
Aplastic anaemia 7

STANOZOLOL vs Alternatives: Which Is Safer?

STANOZOLOL vs STAVUDINE STANOZOLOL vs STELARA STANOZOLOL vs STIRIPENTOL STANOZOLOL vs STIVARGA STANOZOLOL vs STRATTERA STANOZOLOL vs STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE A STANOZOLOL vs STREPTOMYCIN STANOZOLOL vs STREPTOMYCIN\STREPTOMYCIN STANOZOLOL vs STREPTOZOCIN STANOZOLOL vs STRIBILD

Official FDA Label for STANOZOLOL

Official prescribing information from the FDA-approved drug label.